Shareholders have rejected Florenz’s takeover offer, and Bougen is still talking of putting a recapitalisation plan before the board.
Annualised savings of $6m realised from cuts – but will cost $6m to implement in the first year.
Having previously said it would return to pre-2021 profit levels, ‘I think we need to let that go,’ says CEO.
The company’s rising debt levels have been a bugbear for analysts, prompting a capital raise and changes to its corporate strategy.
Milk processor says after ‘significant remedial work’ its shipments should be back to normal by July.
Infrastructure investor gives bullish presentation on wind, solar opportunities in US.
Medicinal cannabis company believes value lies in having its products manufactured overseas.
Four directors, including chair Bruce Hassall, add to their holdings.
The share price dropped about 13.5% in earlier trading today, after interim profit was down 61%.
Telematics company is hunting for partners to help with market access in the US and Canada.